The Board of Directors of Daito Pharmaceutical Co.,Ltd. has authorized a buyback plan on September 14, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,305 JPY | -1.50% | -9.22% | +21.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.00% | 230M | |
+21.63% | 44.12B | |
+22.99% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.61B | |
+60.18% | 13.34B | |
-8.35% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- 4577 Stock
- News Daito Pharmaceutical Co.,Ltd.
- Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.